23 Jul, 2026
According to Straits Research, the global veterinary antimicrobial susceptibility testing market size is valued at $1.22 billion in 2025 and is estimated to reach $2.43 billion by 2034, registering a CAGR of 7.97% during the forecast period 2026–2034.
The global veterinary antimicrobial susceptibility testing market is experiencing steady growth, driven by the rising incidence of antimicrobial resistance in both companion and food-producing animals. The increasing misuse and overuse of antibiotics in livestock and veterinary practices have intensified the need for accurate susceptibility testing to guide targeted therapy and comply with antimicrobial stewardship programs. Growing awareness among veterinarians and animal health authorities about the importance of evidence-based antibiotic selection, along with stricter regulations on antibiotic usage across North America and Europe, is further supporting market expansion.
However, market growth is restrained by factors such as the high cost of automated AST systems, limited access to advanced diagnostic infrastructure in developing regions, and the need for skilled laboratory personnel to perform and interpret test results. Smaller veterinary clinics in middle-income countries rely on empirical treatment due to cost and time constraints, which limit AST adoption. On the opportunity front, technological advancements such as rapid phenotypic AST, automated platforms, and integration of digital data management systems are transforming veterinary diagnostics. Expanding livestock industries in the Asia Pacific and Latin America, along with increasing government and international initiatives to combat AMR under the “One Health” approach, are creating significant growth opportunities.
sales@straitsresearch.com